Summary:

«Medtronic announced U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm™ AI algorithms for use with the LINQ II™ insertable cardiac monitor (ICM) – and the presentation of AccuRhythm AI validation data this week at Heart Rhythm 2021.»

Article written by  Fred Pennic.

30|07|2021

Source:

Hit Consultant

https://hitconsultant.net/2021/07/30/medtronic-fda-clearance-2-ai-algorithms/#.YQvuzC0RpQJ